To access this element change to forms mode OFF
Grant Award View - GA92539
Personalised risk-directed clot prevention for patients with cancer
GA ID:
GA92539
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
20-Apr-2020
Publish Date:
20-Jul-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2021 to 31-Dec-2025
Value (AUD):
$645,205.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Personalised risk-directed clot prevention for patients with cancer
Purpose:
Blood clots are a leading cause of death among cancer patients, second only to cancer itself. This EL1 program includes clinical and laboratory studies to assess the impact of personalised clot prevention for patients receiving cancer treatments in ambulatory care settings. Laboratory studies and evaluation of outcomes among ‘real-world’ patients with cancers at high risk of developing blood clots, will improve understanding of both clots and cancer, to advance research and clinical practice.
GO ID:
GO Title:
Investigator Grants 2020
Internal Reference ID:
GNT1196211
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA